芒硝外敷联合乌司他丁治疗急性胰腺炎的效果及对实验室指标水平的影响

打开文本图片集
Effect of External Application of Mangxiao Combined with Ulinastatin in the Treatment of Acute Pancreatitisand Its Influenceon Laboratory Indicators Levels/FUMingen,YI Suhong.//Medical Innovation of China,2025,22(18):131-134
[Abstract]Objective:To explore the efect of external application of Mangxiao combined with Ulinastatin in thetreatmentofacute pancreatitis (AP)and its influenceonlaboratory indicators levels.Method:A total of 82 patients with APadmited to XinyuPeople's Hospital from June2O23 to June 2024 were selected and grouped bythe random number table method,with 41cases in the experimental groupand41 cases inthe control group.Thecontrol group was treated with Ulinastatin.Based on this,the experimental group was treated with external application of Mangxiao.The therapeutic efect,symptoms disappearance time,laboratory indicators,intestinal mucosal barrier functionand adverse reactions of the two groups were compared.Result: Compared with the control group,the total effectiverateof theexperimental groupwashigher,andthedisappearance timeofabdominal pain,nausea and vomiting and abdominal bloating were earlier ( P <0.05).After treatment,compared with the control group,the levels of amylase (AMY), white blood cellcount (WBC), C reactive protein (CRP),endotoxin (ET),diamine oxidase (DAO) and D-lactic acid in the experimental group were lower,the diferences were statistically significant ( P <0.05). No serious adverse reactions occurred in both group during the treatment period.Conclusion: External appication of Mangxiao combined with Ulinastatincan improve the laboratory indicators and intestinal mucosal barier functionof patients withAP,accelerate the relief ofsymptoms and improve the therapeutic effect,and itis safe.
[Key words]Acute pancreatitisExternal applicationof MangxiaoUlinastatinIntestinal mucosal barrier function
First-author's address: Department of Gastroenterology, Xinyu People's Hospital, Xinyu 338000, China
doi:10.3969/j.issn.1674-4985.2025.18.030
急性胰腺炎(AP)常见临床表现有发热、上腹疼痛、血尿淀粉酶升高等,相关研究认为,其主要因胰酶激活异常而致,通常伴有全身炎症反应和肠黏膜屏障功能受损表现,炎症细胞在分泌过量氧自由基后,会进一步加剧AP炎性损伤,致其他脏器功能障碍[1-2]。(剩余5383字)